You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced breast cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Mammogram and Tissue Study

Active, not recruiting
  • Breast Neoplasms
    • Burlington, Vermont
      University of Vermont
    Jan 26, 2023

    Rectal Cancer Trial in Spain (Durvalumab (MEDI4736))

    Recruiting
    • Rectal Cancer
    • Durvalumab (MEDI4736)
    • Sabadell, Barcelona, Spain
    • +9 more
    Jun 18, 2021

    Breast Cancer Receiving Neo-adjuvant Chemotherapy

    Not yet recruiting
    • Breast Cancer Female
    • molecular analysis of blood and tumor
    • Marseille, France
      Institut Paoli-Calmettes
    Aug 14, 2020

    Breast Cancer Trial in Toulouse (MEAVANTI prothesis, Standard prothesis)

    Recruiting
    • Breast Cancer
    • MEAVANTI prothesis
    • Standard prothesis
    • Toulouse, France
      CHU Rangueil
    Feb 24, 2021

    Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-295S1 with dose escalation stage of 5mg up to 200mg, then expansion

    Recruiting
    • Advanced Malignant Solid Tumors
    • HMPL-295S1 with dose escalation stage of 5mg up to 200mg, then expansion stage with recommended dose of therapeutic cycle of 28 days .
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 30, 2021

    Collection of Samples USOPTIVAL Study

    Recruiting
    • Colorectal Cancer (CRC)
    • Advanced Adenomas (AA)
    • Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
    • Chula Vista, California
    • +15 more
    Feb 10, 2022

    Sintilimab, Cetuximab, Regorafenib,Combine,mCRC Trial (Sintilimab,regofinib,cetuximab)

    Not yet recruiting
    • Sintilimab, Cetuximab, Regorafenib,Combine,mCRC
    • (no location specified)
    Feb 8, 2021

    Non-HPV Locally Advanced Head Neck Cancer Trial in Canada, United States (IMRT, Cisplatin, )

    Active, not recruiting
    Has Results
    • Non-HPV Locally Advanced Head and Neck Cancer
    • IMRT
    • +3 more
    • Birmingham, Alabama
    • +15 more
    Oct 29, 2021

    Synovial Sarcoma Trial in New York (ipilimumab)

    Terminated
    Has Results
    • Synovial Sarcoma
    • ipilimumab
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 23, 2021

    Breast Cancer Trial in Boston (YES portal)

    Completed
    • Breast Cancer
    • YES portal
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 28, 2020

    Platinum-resistant Epithelial Ovarian Cancer Trial in Toronto (Hydroxychloroquine, Itraconazole)

    Completed
    • Platinum-resistant Epithelial Ovarian Cancer
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 1, 2021

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Breast Cancer, Neutropenia Trial in Beijing (PEG-rhG-CSF)

    Completed
    • Breast Cancer
    • Neutropenia
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Oct 26, 2020

    Head and Neck Squamous Cell Carcinoma Trial in Chongqing (Camrelizumab, Concurrent cisplatin chemo, Intensity-modulated

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Jan 16, 2022

    NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • Berazategui, Buenos Aires, Argentina
    • +195 more
    Jan 30, 2023

    Locally Advanced /Metastatic Solid Tumors, Relapsed or Refractory Lymphomas Trial in Beijing, Chengdu (TY101)

    Recruiting
    • Locally Advanced /Metastatic Solid Tumors
    • Relapsed or Refractory Lymphomas
    • Beijing, Beijing, China
    • +2 more
    Aug 12, 2021

    NSCLC Trial in China (Lorlatinib)

    Active, not recruiting
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Hefei, Anhui, China
    • +20 more
    Sep 27, 2021

    Nutritional Preferences and Product Accessibility in Oral

    Withdrawn
    • Breast Carcinoma
    • +6 more
    • Interview
    • Survey Administration
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Dec 10, 2020

    Intraoperative Tissue Identification by Analyzing Surgical Smoke

    Completed
    • Breast Cancer
    • Analysis of electrosurgical smoke.
    • Tampere, Pirkanmaa, Finland
      TAYS Hatanpää
    May 10, 2021

    Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced Trial in Beijing

    Not yet recruiting
    • Mesothelioma, Malignant
    • +2 more
    • Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Dec 27, 2021

    Soft Tissue Sarcoma Trial in China (LVGN6051 and Anlotinib)

    Recruiting
    • Soft Tissue Sarcoma
    • LVGN6051 and Anlotinib
    • Zhenzhou, Henan, China
    • +4 more
    May 31, 2022

    Mesogastrium Metastasis in Colon Cancer

    Recruiting
    • Colon Cancer
      • Wuhan, Hubei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      Jul 20, 2021

      IMMUNOlogical Microenvironment in REctal Adenocarcinoma

      Recruiting
      • Rectal Cancer
      • Immunohistochemistry, Flow citometry, Trascriptome analysis
      • Padova, Italy
        Azienda Ospedale Università di Padova
      Jun 1, 2021

      Advanced Solid Tumors Trial in Changsha, Qingdao (AL8326 tablets)

      Recruiting
      • Advanced Solid Tumors
      • AL8326 tablets
      • Changsha, Hunan, China
      • +1 more
      May 12, 2021

      Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States

      Recruiting
      • Advanced Colorectal Carcinoma
      • +26 more
      • Tampa, Florida
      • +3 more
      Jun 22, 2022